21 Mar 2019 --- Nootropics, or “smart drugs,” have captured the industry’s attention as a new brain health area to watch. Consumers are seeking performance-based formulas that help them reach their peak – not only physically, but also mentally. However, entering this increasingly popular space with a product does not come without its drawbacks. In an era where transparency and efficacy are becoming expected, companies must also substantiate their launches.
